Five Quick-Takes from the ADA 77th Scientific Sessions
Insulin Nation
JUNE 13, 2017
Another major study that was trumpeted by the ADA found SGLT2 use reduced heart disease and kidney disease risk for those with Type 2 diabetes. In the same presentation, another researcher described how the price of insulin has skyrocketed in recent years and that incremental improvements in insulin don’t justify their increased price tag.
61 
Let's personalize your content